SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Lupin
Lupin
BSE: 500257|NSE: LUPIN|ISIN: INE326A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Sep 04, 16:01
1859.25
-3.85 (-0.21%)
VOLUME 73,303
LIVE
NSE
Sep 04, 16:01
1859.60
-2.75 (-0.15%)
VOLUME 1,962,214
News on Lupin
Select Year: 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Six in Sixty: Stocks you should keep on your radar 

2.43 pm | 04 Sep 2015 |  Source: CNBC-TV18

CNBC-TV18's Ekta Batra lists out stocks that you should focus on – ICICI Bank, Punjab National Bank, NMDC, Tata Power, Vedanta, HDFC, Maruti Suzuki,...

Lupin up 1.6%, launches Duloxetine 40 mg DR capsules in US

1.09 pm | 04 Sep 2015 |  Source: Moneycontrol.com

It is the first and only generic Duloxetine formulation to become available in 40 mg dosage strength, Lupin says, adding it is the only generic manufa...

Mkt can rebound post Sep 17, don't let go now: Damani, Kela 

10.58 am | 04 Sep 2015 |  Source: CNBC-TV18

Neither Ramesh Damani nor Madhu Kela — two very smart minds in Dalal Street — are not ready to give up on India. In fact they urge retail investor...

Stocks in news: Wipro, Cipla, Jyothy Lab, Glenmark, Leyland

8.15 am | 04 Sep 2015 |  Source: CNBC-TV18

Wipro | Cipla | Jyothy Labs | Edelweiss Financial | Power Finance Corporation | Pfizer | NBCC | Power Mech | Glenmark Pharma | NMDC | Ashok Leyland | ...

Cipla likely to acquire Hetero Drugs' US business: Sources 

9.59 pm | 03 Sep 2015 |  Source: Moneycontrol.com

Homegrown drug major Cipla is in advance stage talks to acquire Hetero Drugs' US business, which is run under the Camber Pharmaceuticals brand....

Buy Lupin; target of Rs 2280: Motilal Oswal

6.05 pm | 03 Sep 2015 |  Source: Moneycontrol.com

Brokerage house Motilal Oswal is bullish on Lupin and has recommended buy rating on the stock with a target price of Rs 2280, in its research report d...

Hold Lupin, Power Grid: Sudarshan Sukhani 

12.18 pm | 03 Sep 2015 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one may stay invested in Lupin and Power Grid Corporation of India with a view of 3-5 years....

Lannett to buy UCB unit to boost generic drugs portfolio

10.35 am | 03 Sep 2015 |  Source: Reuters

There have been several large deals involving generic drug makers, including industry leader Teva Pharmaceutical Industries Ltd, this year as companie...

Nifty to regain 7900 level; banks attractive: Religare Sec 

9.57 am | 03 Sep 2015 |  Source: CNBC-TV18

In an interview with CNBC-TV18, Manoj Murlidharan of Religare Securities says market will enter range bound zone soon and has put Ninfty target at 790...

Prefer HDFC Bank, ICICI Bank, SBI, Sun Pharma: Dilip Bhat 

4.39 pm | 01 Sep 2015 |  Source: Moneycontrol.com

Dilip Bhat of Prabhudas Lilladher is of the view that one may prefer HDFC Bank, ICICI Bank and SBI for long term....

Six in Sixty: Stocks you should keep on your radar 

3.11 pm | 31 Aug 2015 |  Source: CNBC-TV18

CNBC-TV18's Ekta Batra lists out stocks that you should focus on – Lupin, IndusInd Bank, Power Grid, BHEL, L&T, Adani Ports, IRB Infra, GAIL, Sun Ph...

Sensex can slip to 22K, FY16 GDP sliced to 6.8%: Ambit Cap 

8.40 am | 31 Aug 2015 |  Source: CNBC-TV18

China's slowing economy will take a heavy toll on the Indian economy with high chances of Sensex sliding to 22,000 by year-end, warns Ambit Capital's ...

Buy Lupin, Infosys, Bank of Baroda: Rahul Mohindar 

2.43 pm | 28 Aug 2015 |  Source: CNBC-TV18

Rahul Mohindar of viratechindia.com recommends buying Lupin, Infosys and Bank of Baroda....

RBI, Fed actions to boost mkt; 8100 good buy level: Experts 

9.44 am | 28 Aug 2015 |  Source: CNBC-TV18

VK Sharma of HDFC Securities believes that 8100 is a good buy level for the Nifty....

Lupin gets USFDA nod for generic ulcer drug

6.01 pm | 27 Aug 2015 |  Source: PTI

The company has received final approval for its Omeprazole delayed-release capsules (40 mg) from the United States Food and Drugs Administration (USFD...

Lupin receives FDA approval for generic Prilosec capsules

3.50 pm | 27 Aug 2015 |  Source: Moneycontrol.com

Lupin has received final approval for its Omeprazole delayed-release capsules 40 mg from USFDA to market a generic version of AstraZeneca Pharmaceutic...

Six in Sixty: Stocks you should keep on your radar 

2.40 pm | 27 Aug 2015 |  Source: CNBC-TV18

CNBC-TV18's Reema Tendulkar lists out stocks that you should focus on....

Six in Sixty: Stocks you should keep on your radar 

2.48 pm | 26 Aug 2015 |  Source: CNBC-TV18

CNBC-TV18's Reema Tendulkar lists out stocks that you should focus on....

Top buzzing midcap stocks to trade on August 26 

12.45 pm | 26 Aug 2015 |  Source: CNBC-TV18

Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have - Lupin, BHEL, Mindtree, Arvind Infrastructure and Pow...

Lupin gains 2.5%, gets USFDA nod for anti-inflammatory drug

10.46 am | 26 Aug 2015 |  Source: Moneycontrol.com

Credit Suisse has maintained neutral rating on the company in its report. ...

1 2 3 4 5 6 7 8
Quick Links for Lupin
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.